These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8542577)

  • 1. Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Cancer Res; 1996 Jan; 56(2):259-63. PubMed ID: 8542577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Oncogene; 1996 Apr; 12(8):1653-62. PubMed ID: 8622885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas.
    Meltzer SJ; Yin J; Manin B; Rhyu MG; Cottrell J; Hudson E; Redd JL; Krasna MJ; Abraham JM; Reid BJ
    Cancer Res; 1994 Jul; 54(13):3379-82. PubMed ID: 8012954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent microsatellite instability in oesophageal cancers.
    Muzeau F; Fléjou JF; Belghiti J; Thomas G; Hamelin R
    Br J Cancer; 1997; 75(9):1336-9. PubMed ID: 9155055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability in Barrett's esophagus is related to telomere shortening.
    Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; Li X; Self SG; Gollahon KA; Blount PL; Rabinovitch PS
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1451-7. PubMed ID: 16896031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
    Sanz-Ortega J; Hernández S; Saez MC; Sierra E; Sanz-Ortega G; Torres A; Balibrea JL; Sanz-Esponera J; Merino MJ
    Hepatogastroenterology; 2003; 50(50):404-7. PubMed ID: 12749233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
    Walch AK; Zitzelsberger HF; Bink K; Hutzler P; Bruch J; Braselmann H; Aubele MM; Mueller J; Stein H; Siewert JR; Höfler H; Werner M
    Mod Pathol; 2000 Jul; 13(7):814-24. PubMed ID: 10912943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
    Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history.
    Keller G; Rotter M; Vogelsang H; Bischoff P; Becker KF; Mueller J; Brauch H; Siewert JR; Höfler H
    Am J Pathol; 1995 Sep; 147(3):593-600. PubMed ID: 7677173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer.
    Ahrendt SA; Decker PA; Doffek K; Wang B; Xu L; Demeure MJ; Jen J; Sidransky D
    Cancer Res; 2000 May; 60(9):2488-91. PubMed ID: 10811129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.